ReviewFrontiers in physiology2026
Ovarian tissue quality assessment and fertility preservation strategies enabled by multi-omics and artificial intelligence: current applications and clinical perspectives.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian tissue cryopreservation (OTC) is essential for fertility preservation in cancer survivors, prepubertal girls, and individuals at high risk of premature ovarian insufficiency (POI). Yet conventional evaluation methods, such as histology and follicle counting, provide limited insight into tissue viability, microenvironmental integrity, molecular injury, and oncologic safety. Recent advances in multi-omics, including transcriptomics, single-cell sequencing, proteomics, and spatial transcriptomics, enable high-resolution characterization of follicular heterogeneity, stromal status, and potential malignant contamination. Concurrently, artificial intelligence (AI) offers automated follicle detection, quantitative tissue assessment, and multimodal prediction models that can support individualized clinical decisions. This review summarizes emerging applications of multi-omics and AI in ovarian tissue quality assessment and highlights their potential to transform fertility preservation strategies. Integrating molecular profiling with AI-based prediction may establish a more precise and intelligent framework for tissue selection, transplantation planning, and reproductive outcome prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.